Rakestraw is president and managing director of The Branta Group LLC, a
healthcare company formation, capital investment, and strategic advisory firm.
Over the past 15 years, The Branta Group LLC and its family of companies have
been instrumental in 11 successful IPOs, the development and registration of
several new biopharmaceutical medicines, and the acquisition of multiple biopharmaceutical
companies. He currently serves on the board of directors of Sojournix, Inc, an
asset-focused biopharmaceutical company that he co-founded in 2016. Dr.
Rakestraw received his bachelor's of science from the University of Illinois,
and as a Hertz Fellow, his PhD in chemical engineering from MIT.